Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:PROF NASDAQ:SGHT NASDAQ:SKYA NASDAQ:STEX On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumePROFProfound Medical$6.82+3.8%$6.73$3.76▼$8.95$238.74M0.7256,311 shs60,788 shsSGHTSight Sciences$4.85+4.8%$4.38$3.11▼$9.24$251.92M2.41162,132 shs144,128 shsSKYASkyAI, Inc. Common Stock$1.16-11.5%$1.70$1.13▼$18.23$55.44M2.04244,486 shs213,490 shsSTEXBiosig Technologies$0.98-0.3%$1.08$0.70▼$14.11$179.15M1.851.74 million shs1.57 million shs7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformancePROFProfound Medical+3.81%+5.25%-0.44%+21.57%+18.61%SGHTSight Sciences+4.75%+11.75%-9.85%+31.08%+19.46%SKYASkyAI, Inc. Common Stock-11.45%-19.44%-42.00%-37.30%-80.20%STEXBiosig Technologies-0.30%-17.10%+6.07%-53.22%+98,239,900.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumePROFProfound Medical$6.82+3.8%$6.73$3.76▼$8.95$238.74M0.7256,311 shs60,788 shsSGHTSight Sciences$4.85+4.8%$4.38$3.11▼$9.24$251.92M2.41162,132 shs144,128 shsSKYASkyAI, Inc. Common Stock$1.16-11.5%$1.70$1.13▼$18.23$55.44M2.04244,486 shs213,490 shsSTEXBiosig Technologies$0.98-0.3%$1.08$0.70▼$14.11$179.15M1.851.74 million shs1.57 million shs7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformancePROFProfound Medical+3.81%+5.25%-0.44%+21.57%+18.61%SGHTSight Sciences+4.75%+11.75%-9.85%+31.08%+19.46%SKYASkyAI, Inc. Common Stock-11.45%-19.44%-42.00%-37.30%-80.20%STEXBiosig Technologies-0.30%-17.10%+6.07%-53.22%+98,239,900.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PricePROFProfound Medical 2.00Hold$12.0075.95% UpsideSGHTSight Sciences 2.44Hold$8.1467.91% UpsideSKYASkyAI, Inc. Common Stock 1.00SellN/AN/ASTEXBiosig Technologies 2.00Hold$8.00714.33% UpsideCurrent Analyst Ratings BreakdownLatest SKYA, STEX, SGHT, and PROF Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/28/2026SGHTSight Sciences CitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$4.35 ➝ $5.155/22/2026PROFProfound Medical Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)5/21/2026STEXBiosig Technologies Needham & Company LLCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$9.00 ➝ $8.005/11/2026SGHTSight Sciences Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)5/7/2026PROFProfound Medical Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)5/1/2026STEXBiosig Technologies Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)4/21/2026SKYASkyAI, Inc. Common Stock Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)4/10/2026SGHTSight Sciences Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)4/9/2026STEXBiosig Technologies Needham & Company LLCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$12.00 ➝ $9.003/27/2026PROFProfound Medical Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)(Data available from 6/10/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookPROFProfound Medical$16.10M15.39N/AN/A$1.83 per share3.73SGHTSight Sciences$77.36M3.41N/AN/A$1.21 per share4.01SKYASkyAI, Inc. Common Stock$200K245.46N/AN/A$9.12 per share0.13STEXBiosig Technologies$40K4,465.01N/AN/A$0.83 per share1.18Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DatePROFProfound Medical-$42.57M-$1.24N/AN/AN/A-206.76%-78.88%-64.06%8/13/2026 (Estimated)SGHTSight Sciences-$38.43M-$0.71N/AN/AN/A-46.83%-52.34%-28.49%8/6/2026 (Estimated)SKYASkyAI, Inc. Common Stock-$282.50M-$1.63N/AN/AN/AN/A-157.91%-154.40%N/ASTEXBiosig Technologies-$462.77M-$9.71N/AN/AN/AN/A-717.92%-336.75%N/ALatest SKYA, STEX, SGHT, and PROF EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2026Q1 2026SKYASkyAI, Inc. Common StockN/A-$1.19N/A-$1.19N/A$0.19 million5/14/2026Q1 2026STEXBiosig TechnologiesN/A-$0.27N/A-$0.27N/AN/A5/7/2026Q1 2026PROFProfound Medical-$0.24-$0.19+$0.05-$0.19$4.85 million$5.34 million5/6/2026Q1 2026SGHTSight Sciences-$0.19-$0.24-$0.05-$0.24$18.47 million$19.70 million3/31/2026Q4 2025STEXBiosig TechnologiesN/A-$8.23N/A-$8.23N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthPROFProfound MedicalN/AN/AN/AN/AN/ASGHTSight SciencesN/AN/AN/AN/AN/ASKYASkyAI, Inc. Common StockN/AN/AN/AN/AN/ASTEXBiosig TechnologiesN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioPROFProfound MedicalN/A6.565.71SGHTSight Sciences0.685.865.48SKYASkyAI, Inc. Common StockN/A8.288.08STEXBiosig TechnologiesN/A13.9013.90Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipPROFProfound Medical47.86%SGHTSight Sciences55.51%SKYASkyAI, Inc. Common Stock17.17%STEXBiosig Technologies7.16%Insider OwnershipCompanyInsider OwnershipPROFProfound Medical1.52%SGHTSight Sciences28.90%SKYASkyAI, Inc. Common Stock1.22%STEXBiosig Technologies52.73%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionablePROFProfound Medical15036.34 million35.79 millionOptionableSGHTSight Sciences21054.41 million38.69 millionOptionableSKYASkyAI, Inc. Common Stock5542.32 million41.81 millionNot OptionableSTEXBiosig Technologies50181.80 million85.94 millionN/ASKYA, STEX, SGHT, and PROF HeadlinesRecent News About These CompaniesBiosig Technologies (NASDAQ:STEX) CIO Mitchell Young Williams Sells 23,810 SharesJune 3, 2026 | insidertrades.com[Video Enhanced] Streamex has Created a Compliant Secondary Market for Real World AssetsJune 2, 2026 | thenewswire.comTInsider Buying: Biosig Technologies (NASDAQ:STEX) Chairman Buys 34,000 Shares of StockMay 29, 2026 | insidertrades.com[Video Enhanced] Streamex Adds Microsoft and PayPal Lead Product Designer to High-Level Talent RosterMay 28, 2026 | thenewswire.comTStreamex Corp. and Orca Announce Launch of 24/7 Decentralized Secondary Liquidity Infrastructure for Tokenized Securities; GLDY the Inaugural AssetMay 27, 2026 | globenewswire.comStreamex Corp. Appoints Former Microsoft and PayPal Lead Product Designer Kori Handy as Vice President of Product and DesignMay 26, 2026 | globenewswire.comInsider Buying: Biosig Technologies (NASDAQ:STEX) Chairman Purchases 147,000 Shares of StockMay 22, 2026 | insidertrades.comStreamex Corp. Provides Q1 2026 Earnings and Corporate Update Presentation Recap; Highlights New Partnerships & Key UpdatesMay 21, 2026 | globenewswire.comBiosig Technologies Q1 Earnings Call HighlightsMay 20, 2026 | marketbeat.comStreamex Corp. Announces April 2026 Yield Dividend Distribution for GLDYMay 18, 2026 | globenewswire.comStreamex Corp. Reports Q1 2026 Financial Results and Announces Business & Quarterly Update CallMay 14, 2026 | globenewswire.comStreamex Corp. Provides May 2026 Shareholder UpdateMay 11, 2026 | globenewswire.comStreamex Corp. to Present at the 21st Annual Needham Technology, Media, & Consumer ConferenceMay 7, 2026 | globenewswire.comBiosig Technologies (NASDAQ:STEX) CIO Sells $208,451.77 in StockMay 5, 2026 | insidertrades.comStreamex Corp. Announces First Yield Dividend Distribution for GLDYApril 28, 2026 | globenewswire.comBiosig Technologies (NASDAQ:STEX) CFO Christine Marie Plummer Sells 10,922 SharesApril 18, 2026 | insidertrades.comStreamex Corp. (STEX) Q4 2025 Earnings Call TranscriptApril 8, 2026 | seekingalpha.comStreamex Corp. Announces Webcast Details for Wednesday, April 8 Earnings and Corporate Update PresentationApril 6, 2026 | globenewswire.comStreamex Corp. Highlights Year of Progress, Files Annual Report & Announces Earnings and Corporate Update PresentationApril 1, 2026 | markets.businessinsider.comStreamex Corp. Clarifies and Refutes Inaccurate Claims Regarding Lock-Up Agreements; Co-Founders Morgan Lekstrom & Henry McPhie Enter into Voluntary 1 Year Lock-Up AgreementsMarch 27, 2026 | globenewswire.comStreamex Corp.March 27, 2026 | barrons.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesSpaceX Gets the Attention, But These 4 Stocks Could Get the ReturnsBy Bridget Bennett | May 25, 20265 Stocks Winning the AI Race While Everyone Watches NVIDIABy Bridget Bennett | May 26, 2026The Smart Glasses Gold Rush Is Leaving Old-School Eyewear BehindBy Jeffrey Neal Johnson | May 24, 2026Before the Moon Base Gets Built, These 4 Companies WinBy Thomas Hughes | May 11, 2026TJX Companies Fires on All Cylinders With 9% Revenue GrowthBy Thomas Hughes | May 21, 2026SKYA, STEX, SGHT, and PROF Company DescriptionsProfound Medical NASDAQ:PROF$6.82 +0.25 (+3.81%) Closing price 06/9/2026 04:00 PM EasternExtended Trading$6.86 +0.04 (+0.51%) As of 06/9/2026 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum. The company also offers Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. Profound Medical Corp. is headquartered in Mississauga, Canada.Sight Sciences NASDAQ:SGHT$4.85 +0.22 (+4.75%) Closing price 06/9/2026 04:00 PM EasternExtended Trading$4.85 0.00 (0.00%) As of 06/9/2026 05:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. It operates through two segments, Surgical Glaucoma and Dry Eye. The company's products include OMNI Surgical System, an implant-free glaucoma surgery technology indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma; and SION Surgical Instrument, a manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. It also offers TearCare System, a wearable eyelid technology for adult patients with evaporative dry eye disease due to meibomian gland dysfunction, as well as related components. It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. Sight Sciences, Inc. was incorporated in 2010 and is headquartered in Menlo Park, California.SkyAI, Inc. Common Stock NASDAQ:SKYA$1.16 -0.15 (-11.45%) As of 06/9/2026 04:00 PM EasternSkyAI Inc is developing financial technology platforms focused on users in emerging markets. Its operations include the use of stablecoin-based payment infrastructure and artificial intelligence (AI) technologies to provide financial access, educational tools, and data analysis services for users in Asia, Latin America, and Africa. The company's platform will utilize the Solana blockchain network to support digital asset and on-chain data applications.Biosig Technologies NASDAQ:STEX$0.98 0.00 (-0.30%) Closing price 06/9/2026 04:00 PM EasternExtended Trading$0.99 +0.01 (+0.88%) As of 04:03 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for the procedures of atrial fibrillation, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Corning Is Paving AI's Future With Glass The J.M. Smucker Company’s Dividend: Too Sweet to Ignore? Why's Amazon Suddenly Lagging the S&P 500, and Is It a Warning? Apple's Siri AI Was Finally Announced, So Why Is the Stock Tanking? From Crypto to AI: Insiders Are Trading These 3 Stocks The Case for Intel Over Pure-Play Quantum Firms Has Temu-Owner PDD's Story Changed After Double Miss? Campbell's Soup Stock: Deep Value and a 7% Dividend Yield Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
